D.E. Shaw & Co
LHDX

D.E. Shaw & Co’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

D.E. Shaw & Co’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,866
Closed -$26K – 5712
2022
Q2 		$26K Sell
13,866
-5,782
-29% -$14.1K ﹤0.01% 4965
2022
Q1 		$70K Sell
19,648
-54,917
-74% -$270K ﹤0.01% 5067
2021
Q4 		$642K Buy
+74,565
New +$474K ﹤0.01% 4257

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return

D.E. Shaw & Co's LHDX Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 13,866 shares — an estimated $26K sold.

D.E. Shaw & Co first reported a position in LHDX in Q4 2021 and held it in 3 quarters. The position peaked at $642K in Q4 2021. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 13,866 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $26K.
  • D.E. Shaw & Co first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • D.E. Shaw & Co's Lucira Health, Inc. Common Stock position peaked at $642K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.